证券代码：605123 证券简称：派克新材 公告编号：2025-045 无锡派克新材料科技股份有限公司 关于为全资子公司提供担保及运营期流动性 支持函的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 | | | 被担保人名称 本次担保金额 | 70,000 万元 | 无锡派克新能科技发展有限公司 | | --- | --- | --- | --- | --- | | 担 保 | 对 | | | | | 象 | | 实际为其提供的担保余额 | 0 | 万元（不含本次担保） | | | | 是否在前期预计额度内 | □是 □否 | 不适用 | | | | 本次担保是否有反担保 | □是 否 | □不适用 | 累计担保情况 | 对外担保逾期的累计金额（万元） | 无 | | --- | --- | | 截至本公告日上市公司及其控股 子公司对外担保总额（万元） | 70,000（含本次担保） | | 对外担保总额占上市公司最近一 期经审计净资产的比例（%） | 15.86 | | 特别风险 ...

证券代码：605123 证券简称：派克新材 公告编号：2025-046 无锡派克新材料科技股份有限公司 关于召开2025年第三次临时股东会的通知 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方 式 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一)股东会类型和届次 2025年第三次临时股东会 (二)股东会召集人：董事会 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 10 月 10 日 10 点 00 分 召开地点：公司会议室 (五)网络投票的系统、起止日期和投票时间。 股东会召开日期：2025年10月10日 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2025 年 10 月 10 日 至2025 年 10 月 10 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 9:15-9:25,9:30-1 ...

证券代码：605123 证券简称：派克新材 公告编号：2025-047 无锡派克新材料科技股份有限公司 第四届董事会第五次会议决议公告 （四）本次会议应出席董事 5 人，实际出席董事 5 人。 （五）本次会议由董事长是玉丰先生主持，部分高级管理人员列席了会议。 二、董事会会议审议情况 经与会董事认真审议，表决通过了如下议案： （一）审议通过了《关于为全资子公司提供担保及运营期流动性支持函的议 案》。 具体内容详见公司同日刊登于上海证券交易所网站（www.sse.com.cn）及公 司法定信息披露媒体同日披露的《派克新材关于为全资子公司提供担保及运营期 流动性支持函的公告》（公告编号：2025-045）。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 （一）无锡派克新材料科技股份有限公司（以下或简称"公司"）第四届董 事会第四次会议的召集和召开程序符合《中华人民共和国公司法》、《无锡派克 新材料科技股份有限公司章程》的相关规定。 （二）经全体董事一致同意，本次会议豁免通知时限要求。 （三）本次会议于 ...

Market Overview - The aviation equipment sector increased by 0.67% on September 24, with Zongheng Co. leading the gains [1] - The Shanghai Composite Index closed at 3853.64, up 0.83%, while the Shenzhen Component Index closed at 13356.14, up 1.8% [1] Stock Performance - Zongheng Co. (688070) closed at 57.10, rising by 8.06% with a trading volume of 29,800 lots and a transaction value of 163 million yuan [1] - Other notable performers included: - Hitec High-tech (002023) at 12.33, up 3.44% [1] - Aviation New Technology (300424) at 15.59, up 2.84% [1] - Western Superconducting (688122) at 58.49, up 2.60% [1] Capital Flow - The aviation equipment sector saw a net inflow of 57.50 million yuan from institutional investors, while retail investors contributed a net inflow of 29.80 million yuan [2] - However, speculative funds experienced a net outflow of 355 million yuan [2] Individual Stock Capital Flow - Key stocks with significant capital flow included: - Guangqi Technology (002625) with a net inflow of 21.20 million yuan from institutional investors [3] - AVIC Shenyang Aircraft (600760) with a net inflow of 97.23 million yuan [3] - AVIC Power (600893) with a net inflow of 49.86 million yuan [3]

Core Insights - The report highlights the significant growth potential in the pet medical market, driven by increasing pet ownership and the aging of pets, with a projected market size of 549 billion yuan by 2024 and a potential growth to 1,011 billion yuan by 2030 [10][12] - The report emphasizes the advantages of nationwide chain pet medical institutions in terms of medical technology and platform management, which are crucial for providing comprehensive services and maintaining competitive advantages [13][14] - The report identifies key players in the domestic pet medical market, including New Ruipeng, Ruipai, and Ruichen, which are establishing a competitive landscape with a focus on operational quality and efficiency [14] Company-Specific Insights - Weixinno has signed an investment cooperation agreement with Kunshan Weixin to establish a global new display industry innovation center project with a total investment of approximately 5 billion yuan [4] - Dongshan Precision is planning to issue H shares and list on the Hong Kong Stock Exchange, with discussions ongoing with relevant intermediaries [4] - Hualing Cable intends to acquire control of Anhui San Bamboo Intelligent Technology Co., which produces connectors for high-end applications [4] - Postal Savings Bank announced the absorption and merger of its wholly-owned subsidiary, optimizing its management and business structure [4] - Wolker Materials has approved an investment of up to 1 billion yuan for a new materials project in Jiangsu Province [4] Industry Insights - The report discusses the ongoing trend of "anti-involution" in the express delivery industry, which has led to a decrease in the practice of competing on price, resulting in a noticeable increase in single-ticket revenue for companies like Shentong and Yunda [6][7] - The express delivery industry is experiencing a slowdown in volume growth, with a year-on-year increase of 12.3% in August, indicating a shift towards service quality over price competition [6][8] - The report anticipates that the anti-involution policies will continue to positively impact industry profitability and stock prices, particularly for leading companies like Zhongtong and Yuantong [8]

Core Insights - The report highlights the significant growth potential in the pet medical market, driven by increasing pet ownership and the aging of pets, with a projected market size of 549 billion yuan by 2024 and a potential growth to 1,011 billion yuan by 2030 [10][12] - The report emphasizes the advantages of nationwide chain pet medical institutions in terms of medical technology and platform management, which are crucial for providing comprehensive diagnostic services and maintaining competitive advantages [13][14] - The report identifies the current competitive landscape in the pet medical industry, noting the presence of major players such as New Ruipeng, Ruipai, and Ruichen, and suggests that the industry is transitioning from aggressive expansion to improving operational quality [11][14] Industry Overview - The pet medical industry is positioned at the downstream of the pet industry chain, directly serving pets and their owners through various medical services [9] - The report indicates that the pet medical consumption market is expected to grow at a compound annual growth rate of 10.68% due to increasing consumer willingness to spend on pet healthcare [10] - The current chain rate of pet medical institutions in China is approximately 21.1%, indicating room for growth compared to the 30% chain rate in the U.S. market [11] Company Insights - New Ruipeng is identified as the largest nationwide pet chain medical institution in China, with over 1,500 hospitals across more than 100 cities [14] - Ruipai Pet Hospital has nearly 600 locations and has seen significant growth in patient volume, supported by capital expansion [14] - Ruichen Pet Hospital, a newer entrant, has established over 200 hospitals in major cities, indicating a competitive and expanding market [14]

南财智讯9月23日电，派克新材公告，公司计划使用不超过30,000万元的闲置自有资金进行委托理财， 旨在提高资金使用效率和资产回报率。投资将集中在安全性高、流动性好的理财产品上，不涉及风险投 资。公司已于2025年8月29日召开第四届董事会和监事会会议审议通过此议案，无需提交股东大会审 议。同时，公司将采取多种措施控制投资风险，确保资金安全。 ...

Core Views - The report highlights the significant growth potential in the pet medical service market, driven by increasing pet ownership and the aging of pets, with a projected market size of 549 billion yuan by 2024 and a potential of 1,854 billion yuan if full coverage is achieved [6][7] - The report emphasizes the importance of national chain models in the pet medical industry, noting that the current chain rate is around 21.1%, which has room for improvement compared to the US market's 30% [7][10] - The competitive landscape is characterized by major players such as New Ruipeng, Ruipai, and Ruichen, indicating a stable market structure with a focus on operational quality and efficiency [7][10] Industry Overview - The pet medical industry is positioned at the downstream of the pet industry chain, directly interacting with pets and their owners, providing a range of services from vaccinations to surgeries [5] - The report forecasts a compound annual growth rate (CAGR) of 10.68% for the pet medical market, with expectations of reaching 1,011 billion yuan by 2030 if the pet population continues to grow at 1.5% [6][7] - The report identifies the core competencies of national chain pet medical institutions in terms of medical technology and platform management, which are crucial for providing comprehensive services and maintaining competitive advantages [8][9] Company Insights - Baoli International plans to invest in Nanjing Hongtai Semiconductor Technology Co., Ltd., reflecting confidence in the semiconductor testing equipment sector [4] - Xinda Biologics received approval for a new drug application for a diabetes treatment, indicating growth opportunities in the biopharmaceutical sector [4] - New Xiangwei's subsidiary is increasing its stake in a tech company focused on AI, showcasing strategic investments in high-growth areas [4] - Junhua Technology is expected to positively impact its financial performance through a significant procurement project with the State Grid Corporation [4]

Economic News - The Ministry of Culture and Tourism plans to launch a three-year action plan to boost cultural and tourism consumption, with over 330 million yuan in subsidies [2] - As of the end of August, China's electric vehicle charging infrastructure reached 17.348 million, a 53.5% increase year-on-year [2] - The Federal Reserve lowered the federal funds rate target range by 25 basis points to 4.00%-4.25%, marking its first rate cut since December 2024 [2] - The 12th Beijing Xiangshan Forum opened with over 1,800 participants from more than 100 countries and organizations [2] - Japan's government initiated a national AI strategy to become the most AI-friendly country globally [2] - The 9th China (Tianjin) Nucleic Acid Drug Conference was held, with significant projects signed, focusing on nucleic acid drug development [2] - BP plans to invest over £3.6 billion (approximately $5 billion) annually in the U.S. over the next five years [2] - The People's Bank of China conducted a 487 billion yuan reverse repurchase operation, with a net injection of 195 billion yuan [2] - The People's Bank of China will issue a 600 billion yuan central bank bill with a maturity of six months [2] Key Company Information - Shanghai Construction Group reported that its gold business revenue is less than 0.5% of total revenue, with minimal impact on operations [5] - Guangji Pharmaceutical received approval for the re-registration of its chemical raw material drug Vitamin B6 [5] - CATL stated that sodium-ion batteries have lower energy density than lithium-ion batteries but offer better low-temperature performance and safety [5] - Jitu Express announced a share buyback plan for up to 10% of its B shares, citing undervaluation [5] - New China Life Insurance reported a cumulative premium income of 158.086 billion yuan from January to August 2025, a 21% year-on-year increase [5] Industry Analysis - In August, domestic airlines' capacity increased by approximately 1.7% year-on-year, with a notable improvement in passenger load factor [7] - The overall passenger load factor for listed airlines improved by 0.9 percentage points year-on-year and 3.3 percentage points month-on-month in August [7] - The international route capacity for listed airlines increased by 14.6% year-on-year, with a 2.8 percentage point month-on-month improvement in load factor [9] - The release of the "Self-Discipline Convention for Air Passenger Transport" in August is expected to help stabilize the industry and improve profitability [10] - The domestic automotive market saw a production and sales increase of 8.7% and 10.1% respectively in August, with significant growth in new energy vehicles [12] - New energy vehicle sales accounted for 52.1% of total domestic vehicle sales in August, with a year-on-year increase of 18.3% [13] - The export of new energy vehicles showed strong performance, with a 19.6% year-on-year increase in August [14] - The automotive industry is experiencing a shift towards electrification and intelligent technology, with domestic brands gaining market share [16][17]

一、使用部分闲置募集资金进行现金管理到期赎回情况 证券代码：605123 证券简称：派克新材 公告编号：2025-044 无锡派克新材料科技股份有限公司 关于使用暂时闲置募集资金进行现金管理到期 赎回的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 无锡派克新材料科技股份有限公司（以下简称"公司"）于 2024 年 10 月 29 日召开第三届董事会第十八次会议和第三届监事会第十七次会议，审议通过了 《关于使用暂时闲置的募集资金进行现金管理的议案》，同意公司使用最高额度 不超过 8 亿元人民币的暂时闲置的募集资金进行现金管理，该 8 亿元额度可滚动 使用，具体内容详见上海证券交易所网站（www.sse.com.cn）上发布的相关公告 （公告编号：2024-047）。 2025 年 6 月 12 日，公司使用闲置募集资金人民币 20,000 万元购买了中国银 行股份有限公司的结构性存款产品，2025 年 6 月 13 日，公司使用闲置募集资金 人民币 3,000 万元购买了宁波银行股份有限公司的结构性存款产品，具体内容详 ...